Stars 0 No Patient
Satisfaction Reviews
Why not?


Secondary Specialty:

Neonatal-Perinatal Medicine

Board Certifications:



MD, University of Pittsburgh School of Medicine Pittsburgh, PA, USA


UPMC Children's Hospital of Pittsburgh
Pittsburgh, PA USA


Magee Womens Hospital
Pittsburgh, PA


UPMC Horizon
Magee-Womens Hospital of UPMC
UPMC Northwest
Children's Hospital of Pittsburgh of UPMC
UPMC Mercy
UPMC Altoona

Beverly S. Brozanski, MD


Medical Director, Neonatal Intensive Care Unit, Children's Hospital of Pittsburgh of UPMC
Professor, Department of Pediatrics and Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine
Assistant Research Faculty, Magee-Womens Research Institute

Locations and Directions



Research Interests

  • Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days)="" with="" suspected="" or="" complicated="" intra-abdominal="">
  • Phase 2b Randomized, Double Blind, Placebo Controlled, Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity in Very Low Birth Weight Neonates of BSYX-A110, an Anti-Staphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Infection
  • Trial of Late Surfactant to Prevent BPD: A Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide

View Dr. Brozanski's full list of publications from PubMed.

Biography Summary

Beverly Brozanski, MD, is a member of the UPMC Newborn Medicine Program at Children's Hospital of Pittsburgh of UPMC. She also is Professor at the University of Pittsburgh School of Medicine in the departments of Pediatrics and Obstetrics, Gynecology and Reproductive Sciences.

Dr. Brozanski received her bachelor's degree from Duquesne University, from which she graduated summa cum laude. She received her medical degree from the University of Pittsburgh School of Medicine.

Dr. Brozanski completed her pediatric residency at Children's Hospital and the University of Pittsburgh School of Medicine. She completed her fellowship in Neonatal and Perinatal Medicine at Magee-Womens Hospital and the University of Pittsburgh School of Medicine.

In addition to her clinical and teaching duties, Dr. Brozanski is interested in neonatal outcomes research and cost effectiveness. Dr. Brozanski represents Children’s Hospital in the Children’s Hospital Neonatology Consortium (CHNC). CHNC has partnered with Child Health Corporation of America to develop tools to evaluate the effectiveness of tertiary neonatal intensive care in their unique patient population. Through the systematic collection and analyses of clinical data on all infants admitted to US children’s hospital neonatal intensive care units, CHNC expects to spearhead benchmarking, quality improvement, and research initiatives that have not previously been possible in their patient population. As one of the first Quality Improvement projects for CHNC, Dr. Brozanski is working with nine of the 23 CHNC centers to Determine Practice Standards for Central Line Removal in Neonates with Abdominal Wall Defects.

Dr. Brozanski has also served as site-PI for several clinical investigations, including use of inhaled nitric oxide for the prevention of chronic lung disease, the use of rHu-GCSF to reduce the incidence of preeclampsia-associated neutropenia and the use of early treatment with laser for pre-threshold retinopathy of prematurity.

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and are displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Total Comments: 0